| scholarly article | Q13442814 |
| P50 | author | Salvatore Valitutti | Q42321467 |
| P2093 | author name string | Pichler WJ | |
| Schnyder B | |||
| Frutig K | |||
| von Greyerz S | |||
| Brander KA | |||
| Hari Y | |||
| Zanni MP | |||
| P2860 | cites work | Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions | Q68183652 |
| Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites | Q69941103 | ||
| Chemical aspects of penicillin allergy. The direct penicilloylation of epsilon-amino groups by penicillin at pH 7.4 | Q72815439 | ||
| Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils | Q72839448 | ||
| Sulfamethoxazole is metabolized to the hydroxylamine in humans | Q28319853 | ||
| Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis | Q28336497 | ||
| Direct, MHC-dependent presentation of the drug sulfamethoxazole to human alphabeta T cell clones | Q28379004 | ||
| CD1-restricted T cell recognition of microbial lipoglycan antigens | Q28610594 | ||
| Drug metabolism by leukocytes and its role in drug-induced lupus and other idiosyncratic drug reactions | Q33396340 | ||
| Peptide binding and presentation by mouse CD1. | Q36679018 | ||
| CD1 presentation of microbial nonpeptide antigens to T cells | Q37366274 | ||
| Calcium and T lymphocyte activation | Q38695036 | ||
| Immediate hypersensitivity reactions to penicillin and related antibiotics | Q39489983 | ||
| Selective interaction of Ni with an MHC-bound peptide | Q41080835 | ||
| T-cell recognition of non-peptide antigens | Q41103052 | ||
| Direct presentation of nonpeptide prenyl pyrophosphate antigens to human gamma delta T cells. | Q41289959 | ||
| Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine | Q41330958 | ||
| Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. | Q41346251 | ||
| Serial triggering of many T-cell receptors by a few peptide-MHC complexes | Q41346263 | ||
| Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells. | Q41411454 | ||
| Major histocompatibility complex-independent recognition of a distinctive pollen antigen, most likely a carbohydrate, by human CD8+ alpha/beta T cells | Q42207691 | ||
| Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals. | Q42277543 | ||
| Allele-unrestricted presentation of lidocaine by HLA-DR molecules to specific alphabeta+ T cell clones | Q42541814 | ||
| Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy | Q42548860 | ||
| Characterization of lidocaine-specific T cells | Q42551370 | ||
| Cross-reactivity of T cell lines and clones to beta-lactam antibiotics | Q42554720 | ||
| T cell recognition of penicillin G: structural features determining antigenic specificity | Q42557459 | ||
| Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. | Q52112638 | ||
| Antigen-presenting human T cells and antigen-presenting B cells induce a similar cytokine profile in specific T cell clones. | Q55241240 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lymphocyte | Q715347 |
| P304 | page(s) | 1591-1598 | |
| P577 | publication date | 1998-10-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes | |
| P478 | volume | 102 |
| Q84855257 | 5,6-dihydro-2H-pyranones and 5,6-dihydro-2H-pyridones and their derivatives modulate in vitro human T lymphocyte function |
| Q33367112 | A beta-lactam antibiotic dampens excitotoxic inflammatory CNS damage in a mouse model of multiple sclerosis |
| Q43271432 | A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran |
| Q38161477 | Activation of the TCR complex by small chemical compounds |
| Q34088814 | Advances in molecular toxicology-towards understanding idiosyncratic drug toxicity |
| Q34036255 | Allergic reactions to drugs: involvement of T cells |
| Q28364889 | Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo |
| Q46820532 | Antigenicity of sulfanilamide and its metabolites using fluorescent-labelled compounds |
| Q34117815 | Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir |
| Q42718095 | Avidity determines T-cell reactivity in abacavir hypersensitivity. |
| Q38739489 | Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts |
| Q28660812 | Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells |
| Q43285197 | Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified protein |
| Q35996671 | Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis |
| Q44080528 | Deciphering the immune pathomechanism of cutaneous drug reactions |
| Q45193633 | Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients |
| Q43657385 | Degeneracy and additional alloreactivity of drug-specific human alpha beta(+) T cell clones |
| Q34976476 | Delayed drug hypersensitivity: models of T-cell stimulation |
| Q44446870 | Delayed hypersensitivity reaction to the non-ionic X-ray contrast medium Visipaque (iodixanol). |
| Q43982212 | Determination of interleukin-5 secretion from drug-specific activated ex vivo peripheral blood mononuclear cells as a test system for the in vitro detection of drug sensitization |
| Q52720493 | Dissecting the molecular pathophysiology of drug-induced liver injury. |
| Q36673595 | Evaluation of which reactive metabolite, if any, is responsible for a specific idiosyncratic reaction |
| Q26800980 | Evolving models of the immunopathogenesis of T cell-mediated drug allergy: The role of host, pathogens, and drug response. |
| Q35552886 | Gene polymorphisms within the immune system that may underlie drug allergy |
| Q33582530 | Genotyping for severe drug hypersensitivity |
| Q37963995 | HLA alleles and drug hypersensitivity reactions |
| Q38134171 | HLA and disease: guilt by association |
| Q24555784 | HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol |
| Q47826173 | HLA-associated drug hypersensitivity and the prediction of adverse drug reactions. |
| Q38949927 | HLADR: a database system for enhancing the discovery of biomarkers for predicting human leukocyte antigen-mediated idiosyncratic adverse drug reactions. |
| Q23913782 | Haptenation: chemical reactivity and protein binding |
| Q38285818 | Human leukocyte antigen genetic risk factors of drug-induced liver toxicology |
| Q34976463 | Hypersensitivity reactions to HIV therapy |
| Q37510953 | Immune mediation of hypersensitivity adverse drug reactions: implications for therapy |
| Q34609440 | Immunological principles of T-cell-mediated adverse drug reactions in skin |
| Q34122409 | Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment |
| Q38263760 | Immunological response in Stevens-Johnson syndrome and toxic epidermal necrolysis |
| Q35051172 | Immunopharmacology of hypersensitivity reactions to drugs |
| Q43540928 | Induction of delayed-type hypersensitivity to sulfamethoxazole in mice: role of metabolites |
| Q28346452 | Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells |
| Q41123359 | Lack of cross-toxicity between isoniazid and ethionamide in severe cutaneous adverse drug reactions: a series of 25 consecutive confirmed cases |
| Q35051159 | Lessons from drug allergy: against dogmata |
| Q57302639 | Mechanisms of Adverse Drug Reactions |
| Q37148433 | Mechanisms of drug-induced allergy. |
| Q36440366 | Mechanisms of drug-induced delayed-type hypersensitivity reactions in the skin |
| Q34133689 | Metabolic activation in drug allergies. |
| Q35035443 | Modes of presentation of chemical neoantigens to the immune system |
| Q34819168 | N-oxidation of drugs associated with idiosyncratic drug reactions |
| Q36439171 | Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions |
| Q36623913 | Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis |
| Q38546782 | Pathogenesis of drug allergy--current concepts and recent insights |
| Q57223243 | Personalized medicine for HLA-associated drug-hypersensitivity reactions |
| Q35873680 | Pharmacogenetics of antiretroviral therapy: genetic variation of response and toxicity |
| Q30400366 | Pharmacogenomics of off-target adverse drug reactions |
| Q37226687 | Photoaffinity antigens for human gammadelta T cells |
| Q37356747 | Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant |
| Q34142280 | Redox-modulated pathways in inflammatory skin diseases |
| Q36439187 | Role of bioactivation in drug-induced hypersensitivity reactions |
| Q37992545 | Severe drug eruptions revisited |
| Q27304795 | Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVβ20-1, altering pHLA recognition |
| Q38161484 | T cell responses to drugs and drug metabolites |
| Q34564718 | T cells in drug allergy |
| Q28366339 | T-cell involvement in drug-induced acute generalized exanthematous pustulosis |
| Q37780711 | T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. |
| Q26747638 | T-cell-mediated drug hypersensitivity: immune mechanisms and their clinical relevance |
| Q38054629 | The generation, detection, and effects of reactive drug metabolites |
| Q40619738 | The p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors |
| Q39427540 | The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions |
| Q43726774 | The role of haptic macrophages in regulation of idiosyncratic drug reactions |
| Q26779078 | Update on Advances in Research on Idiosyncratic Drug-Induced Liver Injury |
| Q81591747 | [Immunological mechanisms of cutaneous adverse drug reactions] |
| Q37836561 | γδ T cell receptor ligands and modes of antigen recognition |
Search more.